Body size and excess weight, conventionally assessed using body mass index (BMI), are well-established risk factors for many ...

Separate fact from fiction on obesity with expert insights! Debunk common myths and discover the truth about this complex ...

For more on Immunovant’s new data, go here; for more on Sarepta’s gene therapy, go here; to learn more about Zealand’s deal ...

Health data from people raised during sugar rationing offers insights on chronic disease. It’s hard to escape the fruit ...

Despite a crowded GLP-1 drug development field, Structure's oral small molecule approach and strong financial position offer ...

By 2050, over half of the adults and one third of the youth may be obese. Experts have called for urgent action to prevent ...

Body size and excess weight, conventionally assessed using body mass index (BMI), are well-established risk factors for many types of cancer. However ...

The demand for glucagon-like peptide 1 (GLP-1) receptor agonists for overweight/obesity has created a clinical conundrum for ...

While the number of smokers and heavy drinkers in the Netherlands continues to fall, obesity remains one of the country’s ...

The Nevada Division of Health Care Financing and Policy, which houses the state’s Medicaid program, estimated the proposed ...

Body size and excess weight, conventionally assessed using body mass index (BMI), are well-established risk factors for many types of cancer. However, new research to be presented at this year’s ...